Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
March-2022 Volume 23 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2022 Volume 23 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose

  • Authors:
    • Saúl Ernesto Cifuentes‑Mendiola
    • Leticia Moreno‑Fierros
    • Patricia González‑Alva
    • Ana Lilia García‑Hernández
  • View Affiliations / Copyright

    Affiliations: Laboratory of Dental Research, Section of Osteoimmunology and Oral Immunology, FES Iztacala, National Autonomous University of Mexico, San Sebastián Xhala, Cuautitlán Izcalli 54714, Mexico, Laboratory of Mucosal Immunity, FES Iztacala, National Autonomous University of Mexico, Los Reyes Iztacala, Tlalnepantla 54090, Mexico, Laboratory of Tissue Bioengineering, Dentistry Faculty, National Autonomous University of Mexico, University City, Mexico City 04510, Mexico
    Copyright: © Cifuentes‑Mendiola et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 235
    |
    Published online on: January 21, 2022
       https://doi.org/10.3892/etm.2022.11160
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Patients with type 2 diabetes mellitus (DM2) experience an increased risk of fractures and a variety of bone pathologies, such as osteoporosis. The suggested mechanisms of increased fracture risk in DM2 include chronic hyperglycaemia, which provokes oxidative stress, alters bone matrix, and decreases the quality of hydroxyapatite crystals. Docosahexaenoic acid (DHA), an omega‑3 fatty acid, can increase bone formation, reduce bone loss, and it possesses antioxidant/anti‑inflammatory properties. The present study aimed to determine the effect of DHA on altered osteoblast mineralisation and increased reactive oxygen species (ROS) induced by high glucose concentrations. A human osteoblast cell line was treated with 5.5 mM glucose (NG) or 24 mM glucose (HG), alone or in combination with 10 or 20 µM DHA. The collagen type 1 (Col1) scaffold, the expression of osteocalcin (OCN) and bone sialoprotein type‑II (BSP‑II), the alkaline phosphatase (ALP) specific activity, the mineral quality, the production of ROS and the mRNA expression of nuclear factor erythroid 2‑related factor‑2 (NRF2) were analysed. Osteoblasts cultured in HG and treated with either DHA concentration displayed an improved distribution of the Col1 scaffold, increased OCN and BSP‑II expression, increased NRF2 mRNA, decreased ALP activity, carbonate substitution and reduced ROS production compared with osteoblasts cultured in HG alone. DHA counteracts the adverse effects of HG on bone mineral matrix quality and reduces oxidative stress, possibly by increasing the expression of NRF2.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Kerner W and Brückel J: German Diabetes Association. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 122:384–386. 2014.PubMed/NCBI View Article : Google Scholar

2 

International Diabetes Federation: IDF diabetes atlas eighth edition, 2017.

3 

Farr JN and Khosla S: Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 82:28–34. 2016.PubMed/NCBI View Article : Google Scholar

4 

Carnevale V, Romagnoli E, D'Erasmo L and D'Erasmo E: Bone damage in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 24:1151–1157. 2014.PubMed/NCBI View Article : Google Scholar

5 

Hofbauer LC, Brueck CC, Singh SK and Dobnig H: Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 22:1317–1328. 2007.PubMed/NCBI View Article : Google Scholar

6 

Hamann C, Kirschner S, Günther KP and Hofbauer LC: Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol. 8:297–305. 2012.PubMed/NCBI View Article : Google Scholar

7 

Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC and Margolis KL: Risk of fracture in women with type 2 diabetes: The women's health initiative observational study. J Clin Endocrinol Metab. 91:3404–1310. 2006.PubMed/NCBI View Article : Google Scholar

8 

García-Hernández A, Arzate H, Gil-Chavarría I, Rojo R and Moreno-Fierros L: High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone. 50:276–288. 2012.PubMed/NCBI View Article : Google Scholar

9 

Zhang Y and Yang JH: Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts. J Cell Biochem. 114:2595–2602. 2013.PubMed/NCBI View Article : Google Scholar

10 

Arai M, Shibata Y, Pugdee K, Abiko Y and Ogata Y: Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life. 59:27–33. 2007.PubMed/NCBI View Article : Google Scholar

11 

Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM and Luo SQ: Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun. 314:197–207. 2004.PubMed/NCBI View Article : Google Scholar

12 

Richard D, Kefi K, Barbe U, Bausero P and Visioli F: Polyunsaturated fatty acids as antioxidants. Pharmacol Res. 57:451–455. 2008.PubMed/NCBI View Article : Google Scholar

13 

Rotstein NP, Politi LE, German OL and Girotti R: Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci. 44:2252–2259. 2003.PubMed/NCBI View Article : Google Scholar

14 

Yang YC, Lii CK, Wei YL, Li CC, Lu CY, Liu KL and Chen HW: Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways. J Nutr Biochem. 24:204–212. 2013.PubMed/NCBI View Article : Google Scholar

15 

Darlington LG and Stone TW: Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr. 85:251–269. 2001.PubMed/NCBI View Article : Google Scholar

16 

Högström M, Nordström P and Nordström A: n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: The NO2 study. Am J Clin Nutr. 85:803–807. 2007.PubMed/NCBI View Article : Google Scholar

17 

Fallon EM, Nazarian A, Nehra D, Pan AH, O'Loughlin AA, Nose V and Puder M: The effect of docosahexaenoic acid on bone microstructure in young mice and bone fracture in neonates. J Surg Res. 191:148–155. 2014.PubMed/NCBI View Article : Google Scholar

18 

Farahnak Z, Freundorfer MT, Lavery P and Weiler HA: Dietary docosahexaenoic acid contributes to increased bone mineral accretion and strength in young female sprague-dawley rats. Prostaglandins Leukot Essent Fatty Acids. 144:32–39. 2019.PubMed/NCBI View Article : Google Scholar

19 

Atkinson TG, Barker HJ and Meckling-Gill KA: Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling fischer 344 rats. Lipids. 32:293–302. 1997.PubMed/NCBI View Article : Google Scholar

20 

Watkins BA, Li Y, Lippman HE and Feng S: Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids. 68:387–398. 2003.PubMed/NCBI View Article : Google Scholar

21 

Kim HJ, Ohk B, Yoon HJ, Kang WY, Seong SJ, Kim SY and Yoon YR: Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts. Cell Signal. 29:226–232. 2017.PubMed/NCBI View Article : Google Scholar

22 

Coetzee M, Haag M and Kruger MC: Effects of arachidonic acid and docosahexaenoic acid on differentiation and mineralization of MC3T3-E1 osteoblast-like cells. Cell Biochem Funct. 27:3–11. 2009.PubMed/NCBI View Article : Google Scholar

23 

Moskot M, Jakóbkiewicz-Banecka J, Kloska A, Piotrowska E, Narajczyk M and Gabig-Cimińska M: The role of dimethyl sulfoxide (DMSO) in gene expression modulation and glycosaminoglycan metabolism in lysosomal storage disorders on an example of mucopolysaccharidosis. Int J Mol Sci. 20(304)2019.PubMed/NCBI View Article : Google Scholar

24 

Maurin AC, Chavassieux PM, Vericel E and Meunier PJ: Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone. 31:260–266. 2002.PubMed/NCBI View Article : Google Scholar

25 

Gregory CA, Gunn WG, Peister A and Prockop DJ: An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal Biochem. 329:77–84. 2004.PubMed/NCBI View Article : Google Scholar

26 

Tullberg-Reinert H and Jundt G: In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: Effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem Cell Biol. 112:271–276. 1999.PubMed/NCBI View Article : Google Scholar

27 

Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976.PubMed/NCBI View Article : Google Scholar

28 

Romero-Calvo I, Ocón B, Martínez-Moya P, Suárez MD, Zarzuelo A, Martínez-Augustin O and de Medina FS: Reversible ponceau staining as a loading control alternative to actin in western blots. Anal Biochem. 401:318–320. 2010.PubMed/NCBI View Article : Google Scholar

29 

Wrobel E, Leszczynska J and Brzoska E: The characteristics of human bone-derived cells (HBDCS) during osteogenesis in vitro. Cell Mol Biol Lett. 21(26)2016.PubMed/NCBI View Article : Google Scholar

30 

Bourrat C, Radisson J, Chavassieux P, Azzar G, Roux B and Meunier PJ: Activity increase after extraction of alkaline phosphatase from human osteoblastic membranes by nonionic detergents: Influence of age and sex. Calcif Tissue Int. 66:22–28. 2000.PubMed/NCBI View Article : Google Scholar

31 

Buell MV, Lowry OH, Roberts NR, Chang ML and Kapphahn JI: The quantitative histochemistry of the brain. V. Enzymes of glucose metabolism. J Biol Chem. 232:979–993. 1958.PubMed/NCBI

32 

Figueiredo MM, Gamelas JAF and Martins AG: Characterization of bone and bone-based graft materials using FTIR spectroscopy. In: Infrared Spectroscopy-Life and Biomedical Sciences, Theophile T (ed). IntechOpen, 2012.

33 

Rio DC, Ares M Jr, Hannon GJ and Nilsen TW: Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc. 2010(pdb.prot5439)2010.PubMed/NCBI View Article : Google Scholar

34 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

35 

Manolagas SC: From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 31:266–300. 2010.PubMed/NCBI View Article : Google Scholar

36 

He F, Ru X and Wen T: NRF2, a transcription factor for stress response and beyond. Int J Mol Sci. 21(4777)2020.PubMed/NCBI View Article : Google Scholar

37 

Casado-Díaz A, Santiago-Mora R, Dorado G and Quesada-Gómez JM: The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: Potential implication in osteoporosis. Osteoporos Int. 24:1647–1661. 2013.PubMed/NCBI View Article : Google Scholar

38 

Cunha JS, Ferreira VM, Maquigussa E, Naves MA and Boim MA: Effects of high glucose and high insulin concentrations on osteoblast function in vitro. Cell Tissue Res. 358:249–256. 2014.PubMed/NCBI View Article : Google Scholar

39 

Shi P, Liu H, Deng X, Jin Y, Wang Q, Liu H, Chen M and Han X: Label-free nonenzymatic glycation monitoring of collagen scaffolds in type 2 diabetic mice by confocal Raman microspectroscopy. J Biomed Opt. 20(27002)2015.PubMed/NCBI View Article : Google Scholar

40 

Vestergaard P: Discrepancies in bone mineral density and fracture risk in patients with type 1 and 2 diabetes-a meta-analysis. Osteoporos Int. 18:427–444. 2007.PubMed/NCBI View Article : Google Scholar

41 

Yamamoto M: Insights into bone fragility in diabetes: The crucial role of bone quality on skeletal strength. Endocr J. 62:299–308. 2015.PubMed/NCBI View Article : Google Scholar

42 

Wauquier F, Leotoing L, Coxam V, Guicheux J and Wittrant Y: Oxidative stress in bone remodelling and disease. Trends Mol Med. 15:468–477. 2009.PubMed/NCBI View Article : Google Scholar

43 

Sharma T, Sharma A, Maheshwari R, Pachori G, Kumari P and Mandal CC: Docosahexaenoic acid (DHA) inhibits bone morphogenetic protein-2 (BMP-2) elevated osteoblast potential of metastatic breast cancer (MDA-MB-231) cells in mammary microcalcification. Nutr Cancer. 72:873–883. 2020.PubMed/NCBI View Article : Google Scholar

44 

Mao L, Wang M, Li Y, Liu Y, Wang J and Xue C: Eicosapentaenoic acid-containing phosphatidylcholine promotes osteogenesis: Mechanism of up-regulating Runx2 and ERK-mediated phosphorylation of PPARγ at serine 112. J Funct Foods. 52:73–80. 2019.

45 

Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler BB and De Caterina R: The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA. 103:15184–15189. 2006.PubMed/NCBI View Article : Google Scholar

46 

Rahman MM, Bhattacharya A and Fernandes G: Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol. 214:201–209. 2007.PubMed/NCBI View Article : Google Scholar

47 

Poulsen RC, Wolber FM, Moughan PJ and Kruger MC: Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. Prostaglandins Other Lipid Mediat. 85:42–48. 2008.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cifuentes‑Mendiola SE, Moreno‑Fierros L, González‑Alva P and García‑Hernández AL: Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose. Exp Ther Med 23: 235, 2022.
APA
Cifuentes‑Mendiola, S.E., Moreno‑Fierros, L., González‑Alva, P., & García‑Hernández, A.L. (2022). Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose. Experimental and Therapeutic Medicine, 23, 235. https://doi.org/10.3892/etm.2022.11160
MLA
Cifuentes‑Mendiola, S. E., Moreno‑Fierros, L., González‑Alva, P., García‑Hernández, A. L."Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose". Experimental and Therapeutic Medicine 23.3 (2022): 235.
Chicago
Cifuentes‑Mendiola, S. E., Moreno‑Fierros, L., González‑Alva, P., García‑Hernández, A. L."Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose". Experimental and Therapeutic Medicine 23, no. 3 (2022): 235. https://doi.org/10.3892/etm.2022.11160
Copy and paste a formatted citation
x
Spandidos Publications style
Cifuentes‑Mendiola SE, Moreno‑Fierros L, González‑Alva P and García‑Hernández AL: Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose. Exp Ther Med 23: 235, 2022.
APA
Cifuentes‑Mendiola, S.E., Moreno‑Fierros, L., González‑Alva, P., & García‑Hernández, A.L. (2022). Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose. Experimental and Therapeutic Medicine, 23, 235. https://doi.org/10.3892/etm.2022.11160
MLA
Cifuentes‑Mendiola, S. E., Moreno‑Fierros, L., González‑Alva, P., García‑Hernández, A. L."Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose". Experimental and Therapeutic Medicine 23.3 (2022): 235.
Chicago
Cifuentes‑Mendiola, S. E., Moreno‑Fierros, L., González‑Alva, P., García‑Hernández, A. L."Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose". Experimental and Therapeutic Medicine 23, no. 3 (2022): 235. https://doi.org/10.3892/etm.2022.11160
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team